DebruyneD., RyckelynckJPh, MoulinM., Hurault de LignyB., LevaltierB., BigotM.C.Pharmacokinetics of fluconazole in patients undergoing continuous ambulatory peritoneal dialysis.Clin Pharmacokinet1990; 18: 491–8.
2.
FouldsG., WajszczukC., WeidlerD.J., GargD.C., GibsonP.Steady state parenteral kinetics offluconazole in man. First international conference on drug research in immunology and infectious diseases, New York, 1987, Abstract P6.
3.
ChinT., FongI.W., VandenbrouckeA.Pharmacokinetics of fluconazole in serum and cerebrospinal fluid in a patient with AIDS and cryptococcal meningitis.Pharmacotherapy1990; 10: 305–7.
4.
EbdenP., NeillP., FarrowP.R.Spuctum levels of fluconazole in humans.Antimicrob Agents Chemother1989; 33: 963–4.
5.
HanekeE.Fluconazole levels in human epidermis and blister fluid.Br J Dermatol1990; 123: 273–7.
6.
HouangE.T., ChapatteO., ByrneD., MacraeP.V., ThorpeJ.E.Fluconazole levels in plasma and vaginal secretions of patients after a 150 milligram single oral dose and rate of eradication of infection in vaginal candidiasis.Antimicrob Agents Chemother1990; 34: 909–10.
7.
EisenbergE.S., LevitonI., SoeiroR.Fungal peritonitis in patients receiving peritoneal dialysis: Experience with 11 patients and review of the literature.Rev Infect Dis1986; 8: 309–21.
8.
PerfectJ.R., SavaniD.V., DurackD.T.Comparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and candida pyelonephritis in rabbits.Antimicrob Agents Chemother1986; 29: 57983.
9.
RogersT.E., GalgianiJ.N.Activity of fluconazole (UK 49,858) and ketoconazole against Candida albicans in vitro and in vivo.Antimicrob Agents Chemother1986; 30: 418–22.
10.
YamaguchiH., UchidaK., KawasakiK., MatsunagaT.In vitro activity of fluconazole a novel bistriazole antifungal agent.Jpn J Antibiot1989; 42: 1–16.